论文信息 - Abstract P5-21-07: Phase II study of eribulin in combination with pertuzumab plus trastuzumab for human epidermal growth factor receptor 2 (HER2)-positive advanced or metastatic breast cancer - 字舞流文

Abstract P5-21-07: Phase II study of eribulin in combination with pertuzumab plus trastuzumab for human epidermal growth factor receptor 2 (HER2)-positive advanced or metastatic breast cancer

N. Masuda | S. Morita | M. Toi | S. Ohno | H. Kawaguchi | T. Kawasoe | M. Kashiwaba | H. Yano | M. Hattori | H. Bando | K. Narui | K. Yanagihara | T. Yamashita | R. Nakamura | T. Nagashima | M. Kitada | N. Matsunami | Y. Hasegawa | T. Yoshinami